Cargando…
Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations
Nanostructured lipid carriers (NLCs) loaded with lopinavir (LPV) were prepared by the high-shear homogenization method. The LPV-NLCs formulations were freeze-dried using trehalose as a cryoprotectant. In vitro release studies in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410192/ https://www.ncbi.nlm.nih.gov/pubmed/30823545 http://dx.doi.org/10.3390/pharmaceutics11020097 |
_version_ | 1783402184977678336 |
---|---|
author | Khan, Arshad Ali Mudassir, Jahanzeb Akhtar, Safia Murugaiyah, Vikneswaran Darwis, Yusrida |
author_facet | Khan, Arshad Ali Mudassir, Jahanzeb Akhtar, Safia Murugaiyah, Vikneswaran Darwis, Yusrida |
author_sort | Khan, Arshad Ali |
collection | PubMed |
description | Nanostructured lipid carriers (NLCs) loaded with lopinavir (LPV) were prepared by the high-shear homogenization method. The LPV-NLCs formulations were freeze-dried using trehalose as a cryoprotectant. In vitro release studies in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8) showed a burst release. The optimized freeze-dried formulation (LPV-NLC-7-Tres) had a particle size (PS), polydispersity index (PdI), zeta potential (ZP) and % entrapment efficiency (%EE) of 286.8 ± 1.3 nm, 0.413 ± 0.017, −48.6 ± 0.89 mV and 88.31 ± 2.04%, respectively. The optimized formulation observed by transmission and scanning electron microscopes showed a spherical shape. Differential scanning calorimetry study revealed the absence of chemical interaction between the drug and lipids. In vitro cellular uptake study using Caco-2 cell line showed a higher LPV uptake from LPV-NLC-7-Tres formulation compared to the free LPV-suspension. The 6-month stability study showed a minimum rise of ~40 nm in PS, while no significant changes in PdI, ZP and drug content of the LPV-NLC-7-Tres formulation stored at 5 °C ± 3 °C. The bioavailability of LPV following oral administration of LPV-NLC-7-Tres in male Wistar rats was found 6.98-fold higher than the LPV-suspension. In conclusion, the nanostructure lipid carriers are potential carriers for improving the oral bioavailability of lopinavir. |
format | Online Article Text |
id | pubmed-6410192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64101922019-03-29 Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations Khan, Arshad Ali Mudassir, Jahanzeb Akhtar, Safia Murugaiyah, Vikneswaran Darwis, Yusrida Pharmaceutics Article Nanostructured lipid carriers (NLCs) loaded with lopinavir (LPV) were prepared by the high-shear homogenization method. The LPV-NLCs formulations were freeze-dried using trehalose as a cryoprotectant. In vitro release studies in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8) showed a burst release. The optimized freeze-dried formulation (LPV-NLC-7-Tres) had a particle size (PS), polydispersity index (PdI), zeta potential (ZP) and % entrapment efficiency (%EE) of 286.8 ± 1.3 nm, 0.413 ± 0.017, −48.6 ± 0.89 mV and 88.31 ± 2.04%, respectively. The optimized formulation observed by transmission and scanning electron microscopes showed a spherical shape. Differential scanning calorimetry study revealed the absence of chemical interaction between the drug and lipids. In vitro cellular uptake study using Caco-2 cell line showed a higher LPV uptake from LPV-NLC-7-Tres formulation compared to the free LPV-suspension. The 6-month stability study showed a minimum rise of ~40 nm in PS, while no significant changes in PdI, ZP and drug content of the LPV-NLC-7-Tres formulation stored at 5 °C ± 3 °C. The bioavailability of LPV following oral administration of LPV-NLC-7-Tres in male Wistar rats was found 6.98-fold higher than the LPV-suspension. In conclusion, the nanostructure lipid carriers are potential carriers for improving the oral bioavailability of lopinavir. MDPI 2019-02-25 /pmc/articles/PMC6410192/ /pubmed/30823545 http://dx.doi.org/10.3390/pharmaceutics11020097 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Khan, Arshad Ali Mudassir, Jahanzeb Akhtar, Safia Murugaiyah, Vikneswaran Darwis, Yusrida Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations |
title | Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations |
title_full | Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations |
title_fullStr | Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations |
title_full_unstemmed | Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations |
title_short | Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations |
title_sort | freeze-dried lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: statistical optimization, in vitro and in vivo evaluations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410192/ https://www.ncbi.nlm.nih.gov/pubmed/30823545 http://dx.doi.org/10.3390/pharmaceutics11020097 |
work_keys_str_mv | AT khanarshadali freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations AT mudassirjahanzeb freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations AT akhtarsafia freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations AT murugaiyahvikneswaran freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations AT darwisyusrida freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations |